Silence Therapeutics PLC (SLN)
23.29
+0.29
(+1.26%)
USD |
NASDAQ |
May 20, 15:02
Silence Therapeutics Market Cap: 1.086B for May 20, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 1.072B |
| May 16, 2024 | 1.069B |
| May 15, 2024 | 1.041B |
| May 14, 2024 | 985.45M |
| May 13, 2024 | 970.53M |
| May 10, 2024 | 988.71M |
| May 09, 2024 | 1.070B |
| May 08, 2024 | 1.054B |
| May 07, 2024 | 1.034B |
| May 06, 2024 | 1.021B |
| May 03, 2024 | 1.025B |
| May 02, 2024 | 992.91M |
| May 01, 2024 | 998.50M |
| April 30, 2024 | 1.019B |
| April 29, 2024 | 1.020B |
| April 26, 2024 | 1.007B |
| April 25, 2024 | 1.008B |
| April 24, 2024 | 1.038B |
| April 23, 2024 | 1.049B |
| April 22, 2024 | 1.049B |
| April 19, 2024 | 1.055B |
| April 18, 2024 | 1.026B |
| April 17, 2024 | 1.005B |
| April 16, 2024 | 990.58M |
| April 15, 2024 | 963.07M |
| Date | Value |
|---|---|
| April 12, 2024 | 1.033B |
| April 11, 2024 | 1.042B |
| April 10, 2024 | 983.52M |
| April 09, 2024 | 976.55M |
| April 08, 2024 | 995.61M |
| April 05, 2024 | 983.52M |
| April 04, 2024 | 996.08M |
| April 03, 2024 | 991.43M |
| April 02, 2024 | 987.71M |
| April 01, 2024 | 1.009B |
| March 28, 2024 | 1.004B |
| March 27, 2024 | 1.015B |
| March 26, 2024 | 1.004B |
| March 25, 2024 | 1.017B |
| March 22, 2024 | 1.020B |
| March 21, 2024 | 1.055B |
| March 20, 2024 | 1.065B |
| March 19, 2024 | 1.085B |
| March 18, 2024 | 1.117B |
| March 15, 2024 | 1.062B |
| March 14, 2024 | 1.108B |
| March 13, 2024 | 1.191B |
| March 12, 2024 | 1.204B |
| March 11, 2024 | 1.128B |
| March 08, 2024 | 1.190B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
166.04M
Minimum
Apr 24 2023
1.221B
Maximum
Mar 04 2024
551.12M
Average
552.76M
Median
Dec 22 2022
Market Cap Benchmarks
| Adaptimmune Therapeutics PLC | 276.01M |
| NuCana PLC | 7.654M |
| TC BioPharm (Holdings) PLC | 3.515M |
| Biodexa Pharmaceuticals Plc | 5.701M |
| Autolus Therapeutics PLC | 1.070B |
Market Cap Related Metrics
| PS Ratio | 27.54 |
| Price to Book Value | 49.98 |
| Price | 23.29 |
| Earnings Yield | -6.24% |